Reviva Pharmaceuticals Holdings, Inc.
RVPH
$0.60
$0.047.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.01M | -6.05M | -6.43M | -6.26M | -8.37M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 486.20K | 384.20K | 857.90K | 565.30K | 275.70K |
| Change in Net Operating Assets | -2.06M | 656.70K | -2.62M | -3.41M | 3.85M |
| Cash from Operations | -5.59M | -5.01M | -8.19M | -9.10M | -4.24M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 561.90K | 0.00 |
| Total Debt Repaid | -113.20K | -111.10K | -233.90K | -186.80K | -124.50K |
| Issuance of Common Stock | 8.52M | 10.20M | 241.10K | 16.64M | 3.75M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.41M | 10.09M | 7.30K | 17.02M | 3.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.82M | 5.07M | -8.19M | 7.92M | -619.40K |